Role of platelet-activating factor in hepatocellular Ca2+ alterations during hemorrhagic shock

Journal of Surgical Research

Volumn 72, Issue 2, 1997, Pages 101-106

  Silomon, Malte ^a   Pizanis, Antonius ^a   Larsen, Reinhard ^a   Rose, Stefan ^a  

^a Hand and Reconstructive Surgery ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CALCIUM; GINKGOLIDE B; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CONTROLLED STUDY; HEMORRHAGIC SHOCK; LIPID PEROXIDATION; LIVER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION;

EID: 0030679608     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5171     Document Type: Article

References (43)

1. Faist E., Baue A. E., Dittmer H., Heberer G. Multiple organ failure in polytrauma patients. J. Trauma. 23:1983;775.
2. Bauer C., Roth W., Bahrami S., Marzi I. Attenuation of shock-induced inflammation in the rat liver depends on the time of TNF α-inhibition. J. Mol. Med. 74:1996;51.
3. Flaherty J. T., Weisfeldt M. L. Reperfusion injury. Free Rad. Biol. Med. 5:1988;409.
4. Salgia R., Becker J. H., Sayeed M. M. Altered membrane fluidity in rat hepatocytes during endotoxic shock. Mol. Cell. Biochem. 121:1993;143.
5. Rasmussen H., Barrett P. Q. Calcium messenger system: An integrated view. Physiol. Rev. 64:1984;938.
6. Orrenius S., Burkitt M. J., Kass G. E. N., Dypbukt J. M., Nicotera P. Calcium ions and oxidative cell injury. Ann. Neurol. 32:1992;S33.
7. Moore M. M., Nicotera P., Orrenius S. Biochemical mechanisms of oxidative cell injury in isolated hepatocytes. Cell death: Mechanisms of Acute and Lethal Cell Injury. 1990;Field & Wood, Inc. Blue Bell. p. 179-199.
8. 2+. Am. J. Physiol. 253:1987;R545.
9. 2+. Hepatology. 25:1997;379.
10. 2+. Biochem. Biophys. Res. Commun. 195:1993;874.
11. Chao W., Olson M. S. Platelet-activating factor: receptors and signal transduction. Biochem. J. 292:1993;617.
12. Zhou W., McCollum M. O., Levine B. A., Olson M. S. Inflammation and platelet-activating factor production during hepatic ischemia/reperfusion. Hepatology. 16:1992;1236.
13. 2. Transplantation. 55:1993;1261.
14. Wang K. S., Monden M., Kanai T., Gotoh M., Umeshita K., Ukei T., Mori T. Protective effect of platelet-activation factor antagonist on ischemia-induced liver injury in rats. Surgery. 113:1993;76.
15. Albano E., Bellomo G., Parola M., Carini R., Dianzani M. U. Stimulation of lipid peroxidation increases the intracellular calcium content of isolated hepatocytes. Biochim. Biophys. Acta. 1091:1991;310.
16. 2+. Am. J. Physiol. 253:1992;R549.
17. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265.
18. Barritt G. J., Parker J. C., Wadsworth J. C. A kinetic analysis of the effects of adrenaline on calcium distribution in isolated rat liver parenchymal cells. J. Physiol. 312:1981;29.
19. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95:1979;351.
20. 2+. J. Biol. Chem. 258:1983;6390.
21. Kamiike W., Watanabe F., Hashimoto T., Tagawa K., Ikeda Y., Nakao K., Kawashima Y. Changes in cellular levels of ATP and its catabolites in ischemic rat liver. J. Biochem. 91:1982;1349.
22. Maitra S. R., Geller E. R., Pan W., Kennedy P. R., Higgins L. D. Altered cellular calcium regulation and hepatic glucose production during hemorrhagic shock. Circ. Shock. 38:1992;14.
23. Adkison D., Höllwarth M. E., Benoit J. N., Parks D. A., McCord J. M., Granger D. N. Role of free radicals in ischemia-reperfusion injury to the liver. Acta Physiol. Scand. Suppl. 548:1986;101.
24. Colletti L. M., Kunkel S. L., Walz A., Burdick M. D., Kunkel R. G., Wilke C. A., Strieter R. M. The role of zytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat. Hepatology. 23:1996;506.
25. Bauer C., Marzi I., Bauer M., Fellger H., Larsen R. Interleukin-1 receptor antagonist attenuates leukocyte-endothelial interactions in the liver after hemorrhagic shock in the rat. Crit. Care Med. 23:1995;1099.
26. Stewart A. G., Dubbin P. N., Harris T., Dusting G. J. Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3215.
27. Weber C., Aepfelbacher M., Haag H. Tumor necrosis factor induces enhanced responses to platelet-activating factor and differentiation in human monocytic Mono Mac 6 cells. Eur. J. Immunol. 23:1993;852.
28. Mózes T., Braquet P., Filep J. Platelet-activating factor: an endogenous mediator of mesenteric ischemia-reperfusion-induced shock. Am. J. Physiol. 257:1989;R872.
29. Minor T., Isselhard W., Yamaguchi T. Involvement of platelet activating factor in microcirculatory disturbances after global hepatic ischemia. J. Surg. Res. 58:1995;536.
30. Jones S. B., Romano F. D. Dose- and time-dependent changes in plasma catecholamines in response to endotoxin in conscious rats. Circ. Shock. 28:1989;59.
31. Marzi I., Bauer M., Reisdorf E., Walcher F. Involvement of platelet-activating factor (PAF) in pathological leukocyte-endothelium-interactions in the liver following hemorrhagic shock [Beteiligung des Plättchenaktivierungsfaktors (PAF) an pathologischen Leukozyten-Endothel-Interaktionen in der Leber nach hämorrhagischem Schock]. Zentralbl. Chir. 119:1994;814.
32. van der Vliet A., Bast A. Effect of oxidative stress on receptors and signal transmission. Chem. Biol. Interact. 85:1992;95.
33. Gandhi C. R., Olson M. S. PAF effects on transmembrane signaling pathways in rat Kupffer cells. Lipids. 26:1991;1038.
34. Katnik C., Nelson D. J. Platelet-activating factor-induced increase in cytosolic calcium and transmembrane current in human macrophages. J. Membr. Biol. 134:1993;213.
35. Oshiro H., Kobayashi I., Kim D., Takenaka H., Hobson R. W., Duran W. L-. type calcium channel blockers modulate the microvascular hyperpermeability induced by platelet-activating factor in vivo. J. Vasc. Surg. 22:1995;732.
36. 2+. Cell Calcium. 17:1995;442.
37. Hwang S. B. Specific receptor sites for platelet-activating factor on rat liver plasma membranes. Arch. Biochem. Biophys. 257:1987;339.
38. 2+. FEBS Lett. 251:1989;22.
39. Svetlov S. I., Howard K. M., Miwa M., Flickinger B. D., Olson M. S. Interaction of platelet-activating factor with rat hepatocytes: Uptake, translocation, metabolism, and effects on PAF-acetylhydrolase secretion and protein tyrosine phosphorylation. Arch. Biochem. Biophys. 327:1996;113.
40. Svetlov S. I., Barton J. M., Olson M. S. The specific binding of the platelet-activating factor (PAF) receptor antagonist WEB 2086 and the benzodiazepin flunitrazepam to rat hepatocytes. Life Sci. 58:1996;PL81.
41. 41. Biochem. Biophys. Res. Commun. 174:1991;424.
42. Travers J. B., Li Q., Kniss D. A., Fertel R. H. Identification of functional platelet-activating factor receptors in raji lymphoblasts. J. Immunol. 143:1989;3708.
43. Landon E. J., Jaiswal R. K., Naukam R. J., Rama Sastry B. V. Effects of calcium channel blocking agents on membrane microviscosity and calcium in the liver of the carbon tetrachloride treated rat. Biochem. Pharmacol. 33:1984;3553.